VICOR CORP·4

Jun 23, 2:20 PM ET

Schmidt James F 4

4 · VICOR CORP · Filed Jun 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Vicor (VICR) CFO James F. Schmidt Exercises Options, Sells Shares

What Happened

  • James F. Schmidt (CFO, Treasurer, Secretary and Director) exercised stock option awards on June 22, 2026 (1,216 shares at $32.89 and 908 shares at $44.07; total exercise cost ~$80,010) and sold the same 2,124 shares in a series of open‑market transactions for aggregate proceeds of approximately $765,906.
  • The filing also reports a grant of 548 shares under the company’s Amended and Restated 2000 Stock Option and Incentive Plan (vesting over five years). Several exercise/disposition lines show $0 proceeds, consistent with net settlement/tax withholding entries in the Form 4.

Key Details

  • Transaction date: June 22, 2026 (Form 4 filed June 23, 2026).
  • Exercises: 1,216 shares @ $32.89 ($39,994) and 908 shares @ $44.07 ($40,016) — total 2,124 shares; total exercise cost ≈ $80,010.
  • Open‑market sales: 2,124 shares sold in multiple trades at prices ranging roughly from $351.38 to $367.12; total proceeds ≈ $765,906.
  • Notable footnotes: sales were effected pursuant to a Rule 10b5‑1 trading plan adopted Dec 10, 2025 (F1). The new grant (548 shares) vests over five years (F12). Several sale price entries are reported as weighted averages with per‑trade price ranges detailed in the filing (F2–F11).
  • Shares owned after transaction: not stated in the provided data.
  • Filing timeliness: transaction reported the next business day — not shown as late.

Context

  • This appears to be an exercise followed by immediate sales (a sell‑to‑cover/cashless pattern), which is common when insiders monetize option exercises rather than a fresh open‑market purchase (not necessarily an indicator of positive or negative sentiment).
  • The use of a prearranged 10b5‑1 plan means the sales were executed under a previously adopted trading plan, which reduces the likelihood the trades were based on contemporaneous, undisclosed company information.
  • The new grant vests over time, so those awards are not immediately liquid.

Insider Transaction Report

Form 4
Period: 2026-06-22
Schmidt James F
DirectorCFO, Treasurer, Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-22$32.89/sh+1,216$39,9941,216 total
  • Exercise/Conversion

    Common Stock

    2026-06-22$44.07/sh+908$40,0162,124 total
  • Sale

    Common Stock

    [F1][F2]
    2026-06-22$351.38/sh145$50,9501,979 total
  • Sale

    Common Stock

    [F1][F3]
    2026-06-22$354.11/sh45$15,9351,934 total
  • Sale

    Common Stock

    [F1][F4]
    2026-06-22$356.49/sh90$32,0841,844 total
  • Sale

    Common Stock

    [F1][F5]
    2026-06-22$357.70/sh435$155,5971,409 total
  • Sale

    Common Stock

    [F1][F6]
    2026-06-22$359.84/sh145$52,1771,264 total
  • Sale

    Common Stock

    [F1][F7]
    2026-06-22$360.95/sh280$101,065984 total
  • Sale

    Common Stock

    [F1][F8]
    2026-06-22$362.53/sh480$174,014504 total
  • Sale

    Common Sock

    [F1][F9]
    2026-06-22$363.97/sh190$69,155314 total
  • Sale

    Common Stock

    [F1][F10]
    2026-06-22$365.12/sh169$61,705145 total
  • Sale

    Common Stock

    [F1][F11]
    2026-06-22$367.06/sh145$53,2240 total
  • Award

    Non Qualified Stock Option

    [F12]
    2026-06-22+548548 total
    Exercise: $365.53Exp: 2036-06-22Common Stock (548 underlying)
  • Exercise/Conversion

    Non Qualified Stock Option

    2026-06-221,2163,648 total
    Exercise: $32.89From: 2026-06-21Exp: 2034-06-21Common Stock (1,216 underlying)
  • Exercise/Conversion

    Non Qualified Stock Option

    2026-06-229083,631 total
    Exercise: $44.07From: 2026-06-20Exp: 2035-06-20Common Stock (908 underlying)
Footnotes (12)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.0300 to $365.8000.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.9300 to $367.1200
  • [F12]Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026 and vest over a five year period.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.3800 to $351.3800.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.1100 to $354.1100
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.3000 to $356.6700.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.5000 to $357.9700.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.5700 to $360.4400
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.5800 to $361.2000.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.1100 to $363.0900.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.7800 to $364.4800.
Signature
/s/Quentin A. Fendelet Attorney in Fact for James Schmidt|2026-06-23

Documents

1 file
  • 4
    ownership.xmlPrimary

    4